ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003